Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04944459 · ClinicalTrials.gov registry record · NA
Meditation Utilizing Signals From Electroencephalography in Chronic Pain (MUSE-PAIN) Study
A NA study, sponsored by Center For Interventional Pain and Spine.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT04944459: Completed NA study, sponsored by Center For Interventional Pain and Spine.
NCT04944459 is a NA study that has completed, run by Center For Interventional Pain and Spine. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04944459, a NA study, has completed, sponsored by Center For Interventional Pain and Spine.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This clinical investigation is a prospective, open-label, non-randomized, multi-center study. It is designed to assess the use of the Muse-S meditation system in patients with chronic pain based on clinical follow-up data and exploratory cold pressor testing. Baseline assessments will be taken prior to exposure to Muse-S. Subjects will be followed for 7 weeks for main study endpoints and will continue to be followed through 12 months during a study extension period.
Primary Outcome
Changes from PROMIS-29 scores relative to baseline for each domain evaluated (physical function, anxiety, depression, fatigue, sleep disturbance, ability to participate in social roles and activities, pain interference, and pain intensity). The first seven domains are assessed with 4 questions each; Pain Intensity is measured with a single 11-point numeric rating scale (NRS) from 0 (no pain) to 10 (worst imaginable pain). High scores represent more of the domain being measured. Thus, on symptom-
Interventions
- DEVICE Muse-S headband; InteraXon Inc., RRID:SCR_014418
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-07-12 |
| Est. Completion | 2023-10-19 |
| Phase | NA |
What the finished NCT04944459 record still lists
NCT04944459 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Muse-S headband; InteraXon Inc., RRID:SCR_014418 is the first listed.
NCT04944459 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04944459 about?
NCT04944459 is a clinical study titled "Meditation Utilizing Signals From Electroencephalography in Chronic Pain (MUSE-PAIN) Study". This clinical investigation is a prospective, open-label, non-randomized, multi-center study. It is designed to assess the use of the Muse-S meditation system in patients with chronic pain based on clinical follow-up data and exploratory cold pressor testing. Baseline assessments will be taken prio...
What is the current status of trial NCT04944459?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2021-07-12. Estimated completion is 2023-10-19.
What interventions are being tested in trial NCT04944459?
The interventions under investigation include: Muse-S headband; InteraXon Inc., RRID:SCR_014418 (DEVICE).
Who is sponsoring clinical trial NCT04944459?
This trial is sponsored by Center For Interventional Pain and Spine, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04944459's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI